Aiming to develop a treatment for spinal muscular atrophy (SMA), they investigated if the Na+/H+ channel inhibitor 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) could promote exon 7 inclusion in the SMN2 mRNA. Here, SMN2 is linked to spinal muscular atrophy.